- Home
- ENSC vs WNW Comparison
ENSC vs WNW Comparison
Compare ENSC & WNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- WNW
- Stock Information
- Founded
- ENSC 2003
- WNW 2015
- Country
- ENSC United States
- WNW China
- Employees
- ENSC N/A
- WNW N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- WNW Catalog/Specialty Distribution
- Sector
- ENSC Health Care
- WNW Consumer Discretionary
- Exchange
- ENSC Nasdaq
- WNW Nasdaq
- Market Cap
- ENSC 6.4M
- WNW 5.4M
- IPO Year
- ENSC N/A
- WNW 2020
- Fundamental
- Price
- ENSC $2.46
- WNW N/A
- Analyst Decision
- ENSC
- WNW
- Analyst Count
- ENSC 0
- WNW 0
- Target Price
- ENSC N/A
- WNW N/A
- AVG Volume (30 Days)
- ENSC 149.6K
- WNW 47.6K
- Earning Date
- ENSC 11-11-2025
- WNW 11-14-2025
- Dividend Yield
- ENSC N/A
- WNW N/A
- EPS Growth
- ENSC N/A
- WNW N/A
- EPS
- ENSC N/A
- WNW 9.06
- Revenue
- ENSC $7,413,722.00
- WNW $158,485.00
- Revenue This Year
- ENSC N/A
- WNW N/A
- Revenue Next Year
- ENSC $1,354.55
- WNW N/A
- P/E Ratio
- ENSC N/A
- WNW $0.23
- Revenue Growth
- ENSC 415.58
- WNW N/A
- 52 Week Low
- ENSC $1.62
- WNW $0.95
- 52 Week High
- ENSC $14.67
- WNW $70.00
- Technical
- Relative Strength Index (RSI)
- ENSC 66.12
- WNW N/A
- Support Level
- ENSC $2.35
- WNW N/A
- Resistance Level
- ENSC $2.64
- WNW N/A
- Average True Range (ATR)
- ENSC 0.16
- WNW 0.00
- MACD
- ENSC 0.02
- WNW 0.00
- Stochastic Oscillator
- ENSC 76.79
- WNW 0.00
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About WNW Meiwu Technology Company Limited
Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.